GMPriority Pharma News

Scientific Integrity in Nutraceutical Formulations 24th July 2024 GMPriority Pharma have today been recognised for our work in campaigning for integrity and truth in the labelling of food supplements. Over the past five years, we have proactively characterised multiple commercial liposomal supplements. We have amassed a library of data, which calls into question the legitimacy […]

Meeting Disulfican Ltd Our Chief Scientist, Professor Mohammad Najlah  was delighted to host Professor Weiguang Wang, from the University of Wolverhampton and Vinodh Kannappan, Chief Technology Officer at Disulfican Ltd, to his Anglia Ruskin University labs. During their visit, the group explored numerous opportunities to strengthen their long-term collaboration. Professor Najlah also toured the visitors […]

GMPriority Pharma Unveils Groundbreaking Innovation in Liposomal Dry Powder Technology with Successful Scale-Up of dry SAIFX® GMPriority Pharma is thrilled to announce the successful scale-up of our pioneering liposomal dry powder technology, dry SAIFX®, following a highly productive two-year Research and Development Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This innovative advancement marks a […]